title: Predictors of improved outcome in second pediatric renal transplant recipients.
authors.affiliation: University of Minnesota Hospital and Clinic, Department of Surgery, Minneapolis 55455.
authors.forename: A
authors.initials: A
authors.lastname: Moss
authors.forename: P S
authors.initials: PS
authors.lastname: Almond
authors.forename: A J
authors.initials: AJ
authors.lastname: Matas
authors.forename: K
authors.initials: K
authors.lastname: Gillingham
authors.forename: J S
authors.initials: JS
authors.lastname: Najarian
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone